1. Home
  2. INTS vs CXAI Comparison

INTS vs CXAI Comparison

Compare INTS & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • CXAI
  • Stock Information
  • Founded
  • INTS 2012
  • CXAI N/A
  • Country
  • INTS United States
  • CXAI United States
  • Employees
  • INTS N/A
  • CXAI N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • CXAI EDP Services
  • Sector
  • INTS Health Care
  • CXAI Technology
  • Exchange
  • INTS Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • INTS 33.4M
  • CXAI 33.9M
  • IPO Year
  • INTS 2023
  • CXAI N/A
  • Fundamental
  • Price
  • INTS $2.11
  • CXAI $1.61
  • Analyst Decision
  • INTS Strong Buy
  • CXAI
  • Analyst Count
  • INTS 3
  • CXAI 0
  • Target Price
  • INTS $8.50
  • CXAI N/A
  • AVG Volume (30 Days)
  • INTS 28.4K
  • CXAI 882.7K
  • Earning Date
  • INTS 03-13-2025
  • CXAI 11-12-2024
  • Dividend Yield
  • INTS N/A
  • CXAI N/A
  • EPS Growth
  • INTS N/A
  • CXAI N/A
  • EPS
  • INTS N/A
  • CXAI N/A
  • Revenue
  • INTS N/A
  • CXAI $7,200,000.00
  • Revenue This Year
  • INTS N/A
  • CXAI $3.86
  • Revenue Next Year
  • INTS N/A
  • CXAI $100.00
  • P/E Ratio
  • INTS N/A
  • CXAI N/A
  • Revenue Growth
  • INTS N/A
  • CXAI N/A
  • 52 Week Low
  • INTS $1.50
  • CXAI $1.09
  • 52 Week High
  • INTS $5.94
  • CXAI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • INTS 41.98
  • CXAI 47.82
  • Support Level
  • INTS $1.84
  • CXAI $1.46
  • Resistance Level
  • INTS $2.53
  • CXAI $1.64
  • Average True Range (ATR)
  • INTS 0.32
  • CXAI 0.10
  • MACD
  • INTS -0.02
  • CXAI 0.01
  • Stochastic Oscillator
  • INTS 37.50
  • CXAI 82.61

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

Share on Social Networks: